![Stephen Willard](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Stephen Willard
Directeur Général chez
LONGEVERON INC.
Fortune : 609 669 $ au 31/05/2026
Profil
Stephen H.
Willard is currently Chief Executive Officer at Longeveron, Inc. since 2026.
Mr. Willard is also a Director at Global Life Technologies Corp.
and a Director at The National Science Board since 2018.
Formerly, Mr. Willard was Chief Executive Officer & Director at Cellphire, Inc. from 2013 to 2021, Chief Executive Officer & Secretary at NRX Pharmaceuticals, Inc. in 2024, Executive Director at Nozin, Inc. from 2021 to 2022, Non-Executive Chairman at Flamel Technologies SA from 2012 to 2014, Independent Director at E*TRADE Financial Corp.
from 2012 to 2014, Director at E*TRADE Bank from 2000 to 2014, Director at ETB Holdings, Inc. in 2005, Associate Director-Resolutions at Federal Deposit Insurance Corp.
from 1991 to 1994, Chief Executive Officer at Icapath, Inc., and President at Flamel Technologies, Inc. Education includes a graduate degree from Yale University conferred in 1985 and an undergraduate degree from Williams College conferred in 1982.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
LONGEVERON INC. CLASS A 2,62 % | 01/05/2026 | 789 727 ( 2,62 % ) | 609 669 $ | 31/05/2026 |
Postes actifs de Stephen Willard
| Sociétés | Poste | Début |
|---|---|---|
| LONGEVERON INC. | Directeur Général | 11/02/2026 |
Global Life Technologies Corp.
 Global Life Technologies Corp. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Directeur/Membre du Conseil | - |
The National Science Board | Directeur/Membre du Conseil | 01/01/2018 |
Anciens postes connus de Stephen Willard
| Sociétés | Poste | Fin |
|---|---|---|
Icapath, Inc.
 Icapath, Inc. Miscellaneous Commercial ServicesCommercial Services Develops drug delivery technology that combines PLGA nanoparticles | Directeur Général | 01/10/2025 |
| NRX PHARMACEUTICALS, INC. | Directeur Général | 11/10/2024 |
Cellphire, Inc.
 Cellphire, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical stage biotechnology company that develops platelet-derived therapeutics | Directeur Général | 01/03/2021 |
Flamel Technologies SA
 Flamel Technologies SA Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs | Président | 02/07/2014 |
Formation de Stephen Willard
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
74
Relations au 1er degré
14
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 14 |
|---|---|
E*TRADE Financial Corp.
 E*TRADE Financial Corp. Investment Banks/BrokersFinance Provides online stock brokerage and investing services | Finance |
Flamel Technologies SA
Flamel Technologies SA Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs | Health Technology |
E*TRADE Bank
 E*TRADE Bank Regional BanksFinance Provides banking services | Finance |
Yale University
 Yale University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Williams College
 Williams College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Federal Deposit Insurance Corp.
 Federal Deposit Insurance Corp. Insurance Brokers/ServicesFinance Operates as an insurance agency | Finance |
ETB Holdings, Inc.
 ETB Holdings, Inc. MiscellaneousMiscellaneous Functions as an investment holding company | Miscellaneous |
Flamel Technologies, Inc. | |
The National Science Board | |
Cellphire, Inc.
Cellphire, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical stage biotechnology company that develops platelet-derived therapeutics | Commercial Services |
Longeveron, Inc.
 Longeveron, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which develops cellular therapies for aging-related and life-threatening conditions | Health Technology |
Global Life Technologies Corp.
Global Life Technologies Corp. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
NRX Pharmaceuticals, Inc.
 NRX Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a molecule pharmaceutical company | Health Technology |
Icapath, Inc.
Icapath, Inc. Miscellaneous Commercial ServicesCommercial Services Develops drug delivery technology that combines PLGA nanoparticles | Commercial Services |
